Home / News / Hatchtech gets lice treatment nod from FDA

Hatchtech gets lice treatment nod from FDA

02 August 2020

Posted in — News, The Australian Financial Review

Share

Read more from the Australian Financial Review below.

Learn more

Share

You may also like

02 August 2020

FDA Approves Xeglyze™ for the topical treatment of head lice infestation

Media Release

01 February 2018

No nit picking: Head lice group Hatchtech gets green light to trials

News, The Australian Financial Review

21 October 2014

Hatchtech announces successful results from Phase 2 ovicidal study

Media Release

01 November 2013

Hatchtech gets new VC backing for lice treatment trial

The Australian

View All

Ventured. Gained.
decor